Global market for multiple sclerosis disease-modifying products to reach $14.2 billion by 2018

August 7, 2014

Disease-modifying agents to treat multiple sclerosis (MS) are currently one of the largest classes of pharmaceutical products by sales in the U.S. and throughout the world. The total worldwide market for MS disease-modifying therapies is expected to reach nearly $14.2 billion by the end of 2018. The U.S. will be the primary market for most soon-to-be introduced MS therapies. Europe follows close behind; Japan also represents a large opportunity for a few particularly novel MS drug and biologic candidates.

BCC Research provides an in-depth study of the global multiple sclerosis drugs and biologics market through its report, Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets. According to the report, the global market for multiple sclerosis disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This is expected to grow to $14.2 billion by 2018, with a compound annual growth rate (CAGR) of 5.4% from 2013 to 2018.

RSS Feeds – Pharmaceuticals

Use this report for, but not limited to, the following reasons:

  • Gain an overview of the global market for MS drugs and biologics
  • Analyze global market trends, with data from 2011 to 2013, and projections of CAGRs through 2018
  • Access to detailed profiles of the MS disease-modifying products on the market in the U.S. and around the world
  • Gain an in-sight into how pharmaceutical and biotech companies are pursuing new approaches to treating MS as many of them look to move beyond current approaches
  • Obtain forecast sales by product, company, geographic region, formulation, and indication when possible for the time frame covered, including supporting analyses for these projections
  • Review comprehensive profiles of leading companies in the industry
SAMPLE FIGURE
GLOBAL MARKET FOR THERAPIES TREATING MS, 2011-2018
($ MILLIONS)

1403854898_PHM069B-0

To order your copy of this report (or any of its chapters) or to download the report overview, click here.

Advertisements

Global HIV therapeutics market to reach $19.6 billion by 2018

April 18, 2014

Advanced treatment options and improved methods of diagnosis have helped to moderate the growth of HIV/AIDS. However, there is an ongoing, urgent need for the development of new therapeutics and diagnostic products, as well as proper exploitation of existing options. R&D spending, patent expiries, and improving access to healthcare will shape growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the global market for HIV therapeutics through its report, Diagnostics and Therapeutics for HIV: Global Markets. According to the report, this market was valued at nearly $17.5 billion in 2012 and $18.2 billion in 2013. BCC Research projects the market to grow to $19.6 billion by 2018, and register a five-year compound annual growth rate of 1.5% from 2013 to 2018.

Use this report to:

  • Gain an overview of the global market for HIV therapeutics and diagnostics.
  • Analyze global market trends, with data from 2012 and 2013, and estimates and projections of CAGRs through 2018.
  • Discuss improvements in advanced treatments and diagnostic methods.
  • Assess cost implications for treatments across a wide range of countries.
  • Evaluate ongoing research and the future direction of the market.
  • Review company profile of major players in the market.
SAMPLE FIGURE
GLOBAL HIV MARKET, 2012-2018
($ BILLIONS)

PHM058B-0-LI

To order your copy of this report (or any of its chapters) or to download the complimentary introduction chapter, click here.


Global neurostimulation devices market to reach $4.1 billion by 2018

April 3, 2014

It is estimated that over 100 million people globally suffer from chronic pain annually. While drug therapies are the primary treatment option, neurostimulation devices are increasingly used for pain management. Increasing acceptance of neurostimulation devices for multiple applications, an aging population, and technological advancements, as well as negative factors such as device recalls will shape growth in this market over the near term.

BCC Research provides an in-depth analysis of the global market for neurostimulation devices through its report Neurostimulation: Technologies and Global Markets. According to the report, this market was valued at $3.6 billion in 2012 and $3.8 billion for 2013. BCC Research expects the market to grow to $4.1 billion by 2018, and register a five-year compound annual growth rate of 1.5% from 2013 to 2018.
RSS Feeds – Pharmaceuticals

Use this report to:

  • Gain an overview of the global market for neurostimulation devices.
  • Analyze global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
  • Evaluate individual disorders and variety of neurostimulation options, including deep brain stimulation, transcranial magnetic brain stimulation, spinal cord stimulation, vagal nerve stimulation, sacral nerve stimulation, occipital nerve stimulation, tibial nerve stimulation, gastric electrical stimulation, and closed-loop/responsive stimulation.
  • Evaluate new product launches, current promising clinical trials, and the patent/technological pipeline.
  • Review profiles of major players in the industry.
SAMPLE FIGURE
DISTRIBUTION OF NEUROSTIMULATION DEVICES BY TYPE OF DISORDER CATEGORY 2012-2018
($ MILLIONS)

PHM149A-0-A-LI

To order your copy of this report (or any of its chapters) or to download the complimentary introduction chapter, click here.


Global markets for histone deacetylase inhibitors to reach $954.3 million by 2018

March 12, 2014

Histone deacetylase inhibitors (HDIs) are promising therapeutics that have already shown potential for oncological applications such as cancer detection, diagnosis, and prognosis. Current candidates are demonstrating successful pre-clinical and clinical trials for various other diseases such as neurological ailments, heart diseases, HIV infections, and many others. Prospective pipeline products, collaborations and joint ventures, focused researches, and the growing need of drugs for fatal diseases such as cancer, neurodegenerative diseases, and others will drive tremendous growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the global markets for  HDIs through its report, Histone Deacetylase Inhibitors: Emerging Markets. According to the report, this market was valued at $223.2 million in 2012 and was estimated at  $361.8 million for 2013. BCC Research expects the market to grow to $954.3 million by 2018, and register a five-year compound annual growth rate of 21.4% from 2013 to 2018.
RSS Feeds – Pharmaceuticals

Use this report to:

  • Gain an overview of the global market for histone deacetylase inhibitors.
  • Analyze global market trends, with data from 2011 and 2012, estimates for 2013, and projections of CAGRs through 2018.
  • Evaluate a breakdown of the market for HDIs not only by region, but by application as well.
  • Assess information pertaining to the manufacturing of HDIs as well information on the manufacturing companies involved.
  • Review comprehensive company profiles of leading HDI companies in the market.
SAMPLE FIGURE
GLOBAL HISTONE DEACETYLASE INHIBITOR MARKET BY REGION, 2011-2018
($ MILLIONS)
PHM163A-0-LI

To order your copy of this report or to download the complimentary introduction chapter, click here.


Global markets for advanced drug delivery systems to reach nearly $212.8 billion by 2018

January 7, 2014

Advanced drug delivery systems offer many advantages, including improved therapy by increasing the efficacy and duration of drug activity, decreased dosing frequency, convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. Increasing R&D spending, along with increasing competition, patent expiries, and new technologies will continue to shape growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the global advanced drug delivery systems market through its report Global Markets and Technologies for Advanced Drug Delivery Systems. According to the report, this market was valued at nearly $176.7 billion in 2012 and is expected to reach nearly $182 billion in 2013. BCC Research projects the market to grow to nearly $212.8 billion by 2018, and register a five-year compound annual growth rate of 3.2% from 2013 to 2018.

Use this report to:

  • Gain an overview of the global market for advanced drug delivery systems, including the market as seen by the end users of the different applications.
  • Analyze global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018.
  • Assess the current state, setbacks, innovations, and the future needs of the market.
  • Examine different categories of drug delivery, broken down by market shares of the leading manufacturers and/or suppliers, as well as acquisitions, mergers, and alliances by companies and global organizations.
  • Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter click here .


Global markets for machine vision (MV) system components to reach $23.5 billion by 2019

December 16, 2013

Advances in machine vision technology, including smart cameras and vision-guided robotics, have increased the scope of the market for MV systems components, leading to wider application across all sectors of the economy. Increasing consumer demand for smaller, smarter devices; technological advances in quality control; and significant reductions in production costs will spur tremendous growth in this market for the foreseeable future.

BCC Research provides an in-depth analysis of the global markets for MV system components through its report Global Markets for Machine Vision Technologies. According to the report, this market was estimated at nearly $13.5 billion in 2012 and is expected to reach $15.2 billion in 2014. BCC Research projects the market to grow to nearly $23.5 billion by 2019, and register a five-year compound annual growth rate of 9% from 2014 to 2019.

 RSS Feeds – Pharmaceuticals

Use this report to:

  • Gain an overview of the global market for machine vision (MV) system components.
  • Analyze the global market trends, with data from 2012, estimates for 2013, and projections of CAGRs from 2014 through 2019.
  • Examine the global market for the various components that make up an MV system, as well as the advances in MV technology that have facilitated and accelerated varied applications for industrial as well as nonindustrial use in the near future.
  • Assess the structure of the industries involved in the research, development, design, and manufacture of MV components and systems.
  • Review comprehensive company profiles of major players in the industry.

To order your copy of this report or to download the complimentary introduction chapter click here.


Global Markets For Smoking Cessation Medicine To Reach $2.5 Billion By 2018

September 27, 2013

The growing consumption of cigarettes in developing and poor countries is increasing the mortality rate and health hazards associated with smoking. In addition, the demand for smoking cessation medicines has grown substantially in the developed markets of North America and Europe. These conditions are expected to drive the market for smoking cessation medicines in both developed and developing countries as well as emerging markets in the foreseeable future.

BCC Research provides an in-depth analysis of the global markets for smoking cessation medicine through its report, Medicines for Smoking Cessation: Global Markets. According to the report, this market was valued at $2.11 billion in 2012 and is expected to reach $2.12 billion by 2013. BCC Research projects the market to grow to $2.5 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 3.4% from 2013 to 2018.

 RSS Feeds – Pharmaceuticals

Use this report to:

  • Gain an overview of the global market for medicines used to quit smoking and cope with nicotine withdrawal symptoms.
  • Analyze global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discuss the history and current state of smoking cessation methods, worldwide trends in smoking, and mechanisms of actions such as nicotine replacement therapy, nicotine receptor partial agonist, and antidepressants.
  • Evaluate a list of pipeline products and focus on promising pipeline candidates, as well current patents and new applications.
  • Review comprehensive company profiles of major players in the industry.

This report is intended for executives of pharmaceutical companies who are currently marketing smoking cessation aids; executives of companies that provide third-party manufacturing and development facilities for smoking cessation medications; manufacturers of gum base, resins, alkaloids, and other raw materials for the manufacture of nicotine replacement therapies; developers of novel nicotine delivery systems; and tobacco companies that intend to enter the tobacco transformation market. This study will also benefit entrepreneurs, management consultants, and merger and acquisition (M&A) consultants; financial institutions, venture capitalists, and angel investors; manufacturers and exporters of alternate smoking cessation aids; and government agencies, public health departments, and organizations working in tobacco prevention and control.

To order your copy of this report or its chapter(s) click here.

To download the complimentary Introduction of this report or to explore the detailed Table of Contents, click here.

Please email us at reports@bccresearch.org if you have any questions pertaining to this report.